Ethics, pharmacy, policy and pediatric cancer experts publish recommendations for managing and preventing drug shortages
A group of prominent healthcare experts including bioethicists, pharmacists, policymakers and cancer specialists have proposed concrete steps for preventing and managing a nightmare scenario that is becoming all too common: shortages of life-saving drugs.
In a consensus statement published in the journal Pediatrics, the experts say they sought to move away from the current strategy of reaction to shortages once they have occurred and focus instead on prevention. Using the example of shortages of chemotherapy drugs used for treating children with cancer—therapies proven to have high survival rates for the most common childhood cancers—the group developed “a comprehensive blueprint for action” they say is critical for managing and preventing future drug shortages.
“Although our recommendations were developed with pediatric oncology in mind, and serve as a blueprint for preventing children with cancer from lacking access to essential life-saving medications, we believe that they apply more broadly across medicine to include pediatrics and adult medicine in general,” says Yoram Unguru, a pediatric hematologist/oncologist at the Herman and Walter Samuelson Children’s Hospital at Sinai and faculty member at the Johns Hopkins Berman Institute of Bioethics. Unguru, a coauthor of the consensus statement, was the principal organizer of meetings that led to its creation, bringing together representatives from the Food and Drug Administration (FDA), leadership of the Children’s Oncology Group and The American Society of Pediatric Hematology/Oncology, patient advocacy groups, legal scholars and clinicians.
Some recommendations would represent new norms for healthcare practice, including the sharing of scarce drugs between healthcare institutions and not giving preferential access to patients participating in research studies.
“This statement is significant both for the consensus found by such a diverse group of experts, and for being the first to take seriously the ethical rationale to prevent shortages in the first place,” says Matthew DeCamp, a Johns Hopkins professor at the Berman Institute of Bioethics and Division of General Internal Medicine, and lead author of the consensus statement.
Included in the statement’s six recommendations is a call to develop policies that give equal priority to patients regardless of whether they are participants in research. The authors acknowledge this “may be controversial,” due to the sentiment that fairness requires giving research participants high-priority access to drugs because of their contribution to medical knowledge and future patients. However, the statement’s authors explain that “concerns over undue inducement, public perception, and the imperative to use drugs for indications for which evidence of benefit exists outweigh arguments for giving priority access to research participants.”
For each recommendation the statement also includes potential barriers to its implementation. A centralized information source of drug supply information, for instance, faces the risk that such information will encourage hoarding of existing supplies, including so-called “gray market” suppliers that sell scarce drugs for inflated prices. The statement calls for new policies for both reporting and avoiding these markets, though acknowledges the temptation of healthcare providers to use them in a shortage, when their patients are in need.
The Latest on: Shortages of life-saving drugs
via Google News
The Latest on: Shortages of life-saving drugs
- Crisis over shortage of Remdesivir, Fabiflu to end by next fortnighton May 1, 2021 at 1:10 am
An unprecedented surge in demand of some crucial medicines, used in treating Covid patients, has created a mess. Now companies like Cipla or Cadila, a..
- Seized drugs being put into immediate useon April 30, 2021 at 8:29 pm
Learning lessons from the past, the Telangana police are now accompanied by the Drug Inspectors while catching gangs selling drugs used for Covid-19 treatment illegally.
- Centre imports Remdesivir from other countries amid shortage; 75k vials to arrive soonon April 30, 2021 at 3:12 am
It is now being reported that the Government of India has started importing the life-saving drug Remdesivir from other countries. The first consignment of 75,000 Redmesivir vials is to arrive in India ...
- Faced with drugs shortage, Indian pharma asks envoy to stop Chinese cargo suspensionon April 29, 2021 at 7:15 am
China suspended for 15 days cargo flights by Sichuan Airlines that transports medical supplies to India. India imports 70% of its pharmaceutical raw materials from China.
- HM warns black marketeers of oxygen and life saving drugson April 28, 2021 at 11:12 am
Mahmood Ali has reiterated that the State government is committed to initiate stringent action against those indulging in black marketing of oxygen and other life-saving drugs in view of the steep ...
- No shortage of beds, oxygen and life saving drugs in UP: CMon April 26, 2021 at 5:22 am
Chief Minister of Uttar Pradesh, Yogi Adityanath on April 26 said there is no shortage of beds, oxygen and life saving drugs in the state, amid COVID second wave. “In the last 3 days, fresh COVID19 ...
- COVID Treatment: Amid shortage of costly Tocilizumab, these life-saving drugs can help treat critically ill COVID patientson April 26, 2021 at 1:51 am
COVID Treatment There is a massive shortage of Tocilizumab injection and its only importer Cipla has also said that they do not know when the stock would be refilled here s all you need to know ...
- Shortage Of Anti-retroviral Drugs For HIV Patients In Kenyaon April 23, 2021 at 4:12 am
People living with HIV and AIDS in Kenya say they could die because of a shortage of anti-retroviral medicines after the government decided to impose taxes on the life-saving drugs.
- Hyderabad: Covid patients kin toil to get life-saving drugson April 20, 2021 at 6:51 pm
Helpless kin regularly standing in queue at a retail outlet in Moosapet to get their hands-on life-saving drug at MRPBlack marketing of Remdesivir rising in the City With spike in Covid-19 ...
- "Not Life-Saving Drug": Centre Clarifies On Remdesiviron April 19, 2021 at 5:32 am
Antiviral drug Remdesivir is not a life-saving drug and its "unnecessary or irrational" use on Covid patients is unethical, the centre tweeted on Monday, amid massive demand for the medicine triggered ...
via Bing News